Laboratory for Cell and Gene Medicine
Our Mission is to bridge the "bench to bedside" gap by creating quality manufacturing processes for cell and gene therapies for treating patients with incurable disease.
Working to Cure the Incurable
At the Stanford Laboratory for Cell and Gene Medicine (LCGM) we're working to cure the incurable alongside world-class researchers. Our state-of-the-art cGMP facility provides support and services to clinical investigators during the entire arc of translational research activities including consulting, technology transfer, process and analytical development, clinical manufacturing and regulatory affairs. Cell and Gene therapy creates opportunities to cure the incurable. Our team of highly skilled professionals work with centers across Stanford Medicine, such as the Center for Definitive and Curative Medicine and the Stanford Cancer Institute, and industry partners to treat patients with incurable disease.
Featured Stories:
Combined stem cell transplant and kidney transplant prove a winning combination against autoimmune FSGS. Full story here.
